Aortic coarctation medical therapy

Revision as of 16:40, 7 October 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Aortic coarctation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aortic Coarctation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

Chest X-Ray

CT

MRI

Angiography

Echocardiography

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Aortic coarctation medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aortic coarctation medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aortic coarctation medical therapy

CDC on Aortic coarctation medical therapy

Aortic coarctation medical therapy in the news

Blogs on Aortic coarctation medical therapy

Directions to Hospitals Treating Aortic coarctation

Risk calculators and risk factors for Aortic coarctation medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S.[2], Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S.[4]

Overview

The treatment choice depends on the patients age of presentation, severity, the location of the coarctation and other associated anomalies. For children who present early, the role of medical management is for stablizing the patient for surgery. However, in older kids and adolescent presenting with hypertension treatment is guided towards correction of hypertension and other associated anomalies. Beta blocker is treatment of choice for both pre and post operative hypertension.

Medical therapy

Early presentation

Treatment in patients with early presentation of coarctation of aorta is supportive, symptomatic and the aim is to stabilize the patient for surgical procedure or catheter intervention.

  • Ventilatory support in patients with respiratory distress
  • Congestive heart failure - Diuretics, Ionotropes
  • Hypotension - Ionotropes
  • PgE1 (prostaglandin E1) - Given to keep the ductus arteriosus patent.
  • In patients with other associated cardiac defects if the coarctation has a significantly adverse effect on the clinical status, the coarctation should be initially relieved with surgery or balloon angioplasty and the patient reassessed with regard to need for intervention for the associated defects.

Late presentation

Late presenters usually have hypertension. Beta blocker is the treatment of choice for hypertension in these patients both pre and post operatively [1].

Preoperative

  • Beta blockers are the treatment of choice.
  • Caution should be taken as too much control of hypertension in upper limb can cause hypotension in lower limbs.
  • Surgical treatment of the lesion should not be delayed for the correction of hypertension [2].

Post-operative

References

  1. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C (2004). "Expert consensus document on beta-adrenergic receptor blockers". European Heart Journal. 25 (15): 1341–62. doi:10.1016/j.ehj.2004.06.002. PMID 15288162. Retrieved 2012-04-14. Unknown parameter |month= ignored (help)
  2. Rao PS (1995). "Should balloon angioplasty be used instead of surgery for native aortic coarctation?". British Heart Journal. 74 (6): 578–9. PMC 484108. PMID 8541158. Retrieved 2012-04-14. Unknown parameter |month= ignored (help)

Template:WH Template:WS